Patents by Inventor Andrew D. Levin

Andrew D. Levin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20200360275
    Abstract: The invention relates to inhalable imatinib formulations, manufacture, and uses thereof.
    Type: Application
    Filed: May 14, 2020
    Publication date: November 19, 2020
    Inventors: Ben Dake, Ralph Niven, Andrew D. Levin
  • Publication number: 20200352894
    Abstract: The present disclosure provides certain combination therapy technologies that are particularly useful for treating one or more diseases, disorders, or conditions that may be related to abnormal metabolism. In some embodiments, provided technologies provides combinations of TCA cycle acids and ketone bodies. In some embodiments, provided technologies provides combinations of TCA cycle acids and other carboxylic acids.
    Type: Application
    Filed: July 24, 2020
    Publication date: November 12, 2020
    Inventor: Andrew D. Levin
  • Patent number: 10786476
    Abstract: The present disclosure provides certain combination therapy technologies that are particularly useful for treating one or more diseases, disorders, or conditions that may be related to abnormal metabolism. In some embodiments, provided technologies provides combinations of TCA cycle acids and ketone bodies. In some embodiments, provided technologies provides combinations of TCA cycle acids and other carboxylic acids.
    Type: Grant
    Filed: February 23, 2017
    Date of Patent: September 29, 2020
    Assignee: IMBRIA PHARMACEUTICALS, INC.
    Inventor: Andrew D. Levin
  • Publication number: 20200140375
    Abstract: Compositions and methods for treating conditions associated with altered TCA cycle metabolism are provided.
    Type: Application
    Filed: July 24, 2018
    Publication date: May 7, 2020
    Applicants: IMBRIA PHARMACEUTICALS, INC., IMBRIA PHARMACEUTICALS, INC.
    Inventor: Andrew D. Levin
  • Publication number: 20200138962
    Abstract: Compositions and methods for increasing efficiency of cardiac metabolism are provided.
    Type: Application
    Filed: December 20, 2019
    Publication date: May 7, 2020
    Inventor: Andrew D. Levin
  • Publication number: 20200138963
    Abstract: Compositions and methods for increasing efficiency of cardiac metabolism are provided.
    Type: Application
    Filed: December 20, 2019
    Publication date: May 7, 2020
    Inventor: Andrew D. Levin
  • Patent number: 10556013
    Abstract: Compositions and methods for increasing efficiency of cardiac metabolism are provided.
    Type: Grant
    Filed: June 18, 2018
    Date of Patent: February 11, 2020
    Assignee: IMBRIA PHARMACEUTICALS, INC.
    Inventor: Andrew D. Levin
  • Publication number: 20190314319
    Abstract: The present disclosure provides certain combination therapy technologies that are particularly useful for treating one or more diseases, disorders, or conditions that may be related to abnormal metabolism. In some embodiments, provided technologies provides combinations of TCA cycle acids and ketone bodies. In some embodiments, provided technologies provides combinations of TCA cycle acids and other carboxylic acids.
    Type: Application
    Filed: February 23, 2017
    Publication date: October 17, 2019
    Inventor: Andrew D. Levin
  • Publication number: 20190262288
    Abstract: The present disclosure provides certain N-Acylethanolamide derivatives, and uses relating thereto.
    Type: Application
    Filed: October 12, 2017
    Publication date: August 29, 2019
    Inventor: Andrew D. Levin
  • Publication number: 20190216936
    Abstract: Compositions and methods for increasing efficiency of cardiac metabolism are provided.
    Type: Application
    Filed: March 26, 2019
    Publication date: July 18, 2019
    Inventor: Andrew D. Levin
  • Publication number: 20190153032
    Abstract: The present disclosure provides certain chiral peptide agents, and uses relating thereto.
    Type: Application
    Filed: April 10, 2017
    Publication date: May 23, 2019
    Inventor: Andrew D. Levin
  • Patent number: 5979280
    Abstract: The invention provides an electronics board assembly apparatus which includes a base, a slide, an arm, a punch, a bracket, a roller member and at least a first engagement component. The slide is mounted to the base for sliding movement along the base. The arm extends upwardly firm the base and the punch is located on the arm in a position over the slide. The roller member is rotatable mounted to the bracket. Movement of the slide into a first position causes the roller member to come to rest in the engagement surface.
    Type: Grant
    Filed: April 13, 1998
    Date of Patent: November 9, 1999
    Assignee: Intel Corporation
    Inventors: Andrew D. Levin, Mike A. Witkowski